Chaudhuri Appointed to Thesan Pharmaceuticals Board of Directors

Thesan Pharmaceuticals, a biotechnology company focused on the development and commercialization of novel drugs for the treatment of dermatological conditions, has announced the appointment of Bhaskar Chaudhuri, PhD, to its Board of Directors. With more than 25 years of experience in pharmaceuticals—including management, and research and development—Dr. Chaudhuri most recently served as president of Valeant Pharmaceuticals before becoming an operating partner at Frazier Healthcare. Prior to joining Valeant, Dr. Chaudhuri also served as president and CEO of Dow Pharmaceuticals.

"We are delighted to have Bhaskar join our Board at this time," said Gordon Foulkes, CEO of Thesan. "His superb track record of developing dermatology drugs, his commercialization expertise, and leadership role in the sale of multiple dermatology companies will be a tremendous help to Thesan going forward as we continue to build our Executive leadership team for the future."